녹십자

006280KOSPI의약품 제조업

46.5 / 100

Reference Date: 2026-04-13

Financial Score12.0 / 40

News Sentiment14.4 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 5.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

LG Chem is a pharmaceutical company specializing in blood products and vaccines, with 2025 consolidated sales reaching 19.9 trillion won, a 18.54% increase from the previous year. Key products include ALYGLO, successfully launched in the U.S. market, the WHO-certified chickenpox vaccine 'BariCella', and the hemophilia treatment 'Greenjin E' approved in China. The company is focused on global expansion through strategic products and innovation.

Number of Employees

2,351people

Average Salary

73.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 14.804.0Point

PBR

1.21Industry Average 1.042.5Point

Higher than industry avg (caution)

ROE

-2.07Industry Average 4.420.0Point

Well below industry avg

Debt Ratio

30.91Industry Average 11.980.0Point

2.6x industry avg (risky)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲54.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -2.1% (declining, 3yr)

Detailed News Sentiment

32 totalPositive 8Neutral 19Negative 0Average Sentiment Score 59.3

Detailed Momentum

52-week position5.0Point

52w mid range (42%)

Current 144,300Won52-week high 180,30052-week low 117,500

1-month return2.0Point

1m -5.19% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0

Neutral[기재정정]정기주주총회결과2026-03-31
Neutral타법인주식및출자증권처분결정2026-03-31
Neutral최대주주등소유주식변동신고서2026-03-27
Neutral정기주주총회결과2026-03-26
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26